bortezomib,lenalidomide,busulfan,dexamethasone
takeda
day 3 #ims2022 plenary abstract session nct01916252: phase 3 - bortezomib, lenalidomide &amp; iv busulfan under 65 - (gem2012menos65) pethema. #mmsm #multiplemyeloma #curemyeloma 
Multiple Myeloma Education Platform for Myeloma Community